VanEck Associates’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-200,190
| Closed | -$6.03M | – | 745 |
|
|
2017
Q4 | $6.03M | Sell |
200,190
-100,054
| -33% | -$3.01M | 0.03% | 271 |
|
|
2017
Q3 | $11.3M | Buy |
300,244
+32,470
| +12% | +$1.22M | 0.06% | 232 |
|
|
2017
Q2 | $7.47M | Buy |
267,774
+54,202
| +25% | +$1.51M | 0.04% | 246 |
|
|
2017
Q1 | $7.34M | Buy |
213,572
+6,130
| +3% | +$211K | 0.03% | 261 |
|
|
2016
Q4 | $5.98M | Sell |
207,442
-589,079
| -74% | -$17M | 0.03% | 269 |
|
|
2016
Q3 | $25.3M | Buy |
+796,521
| New | +$25.3M | 0.12% | 115 |
|